U.S. market Closed. Opens in 6 hours 6 minutes

GLSI | Greenwich LifeSciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue3.61K3.61K3.61K3.61K3.61KN/A
Gross Profit-3.61K-3.61K-3.61K-3.61K-3.61KN/A
Operating Expenses9.33M8.04M4.60M1.86M3.43M1.69M
Selling, General & Admin1.63M1.56M1.04M806.19K818.89K419.64K
Research & Development7.70M6.48M3.56M1.06M2.61M1.27M
Other Operating Expenses0N/AN/AN/AN/AN/A
Operating Income-9.33M-8.04M-4.60M-1.86M-3.43M-1.69M
Other Expenses / Income436.06K215.02K27.37K832.003.00N/A
Before Tax Income-8.89M-7.83M-4.57M-1.86M-3.43M-1.69M
Income Tax Expenses-2.00-215.02K-27.37K-832.003.00N/A
Net Income-8.89M-7.61M-4.54M-1.86M-3.43M-1.69M
Interest ExpensesN/A-215.02KN/AN/AN/AN/A
Basic Shares Outstanding12.85M12.91M12.94M12.70M11.74M11.97M
Diluted Shares Outstanding12.85M12.91M12.94M12.70M11.74M11.97M
EBITDA-9.32M-8.04M-4.59M-1.86M-3.42M-1.69M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-8.89M-8.04M-4.57M-1.86M-3.43M-1.69M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙